Provided by Tiger Fintech (Singapore) Pte. Ltd.

Co-diagnostics Inc.

0.4925
+0.00511.05%
Volume:48.55K
Turnover:24.33K
Market Cap:15.73M
PE:-0.36
High:0.5198
Open:0.4901
Low:0.4724
Close:0.4874
Loading ...

Co-Diagnostics, Inc. and CoSara to Host HPV and Cancer Symposium on International HPV Day 2025

PR Newswire
·
03 Mar

Penny Stock Co-Diagnostics Withdraws FDA Application For COVID-19 Test, Plans To Submit Enhanced Version

Benzinga
·
24 Feb

BRIEF-Co-Diagnostics Announces Intention To Submit Enhanced Version Of Covid-19 Test To FDA

Reuters
·
22 Feb

Co-Diagnostics Plans to Seek FDA Clearance for Enhanced Version of COVID-19 Test

MT Newswires Live
·
22 Feb

Co-Diagnostics Withdraws FDA Application for Covid Test

Dow Jones
·
22 Feb

Co-Diagnostics withdraws 510k application to FDA for Co-Dx PCR COVID-19 Test

TIPRANKS
·
22 Feb

Co-Diagnostics, Inc. Announces Intention to Submit Enhanced Version of Covid-19 Test to FDA for 510(K) Clearance

THOMSON REUTERS
·
22 Feb

Co-Diagnostics, Inc. Announces Intention to Submit Enhanced Version of COVID-19 Test to FDA for 510(k) Clearance

PR Newswire
·
22 Feb

Co-Diagnostics, Inc. to Exhibit at BioUtah's 2025 Life Sciences Day on the Hill

PR Newswire
·
30 Jan

Co-Diagnostics, Inc. to Participate at the Nasdaq Live from MarketSite Broadcast at Silicon Slopes 2025

PR Newswire
·
07 Jan

Co-Diagnostics, Inc. and CoSara Diagnostics to Inaugurate New Oligo Facility

PR Newswire
·
10 Dec 2024

Co-Diagnostics Price Target Maintained With a $1.50/Share by HC Wainwright & Co.

Dow Jones
·
11 Nov 2024

Co-Diagnostics Third Quarter 2024 Earnings: Beats Expectations

Simply Wall St.
·
10 Nov 2024

Co-Diagnostics Inc (CODX) Q3 2024 Earnings Call Highlights: Navigating Revenue Decline and ...

GuruFocus.com
·
08 Nov 2024

Co-Diagnostics Inc reports results for the quarter ended in September 30 - Earnings Summary

Reuters
·
08 Nov 2024

Co-Diagnostics Q3 2024 GAAP EPS $(0.32) Beats $(0.33) Estimate, Sales $641.141K Beat $375.000K Estimate

Benzinga
·
08 Nov 2024